{"nct_id":"NCT06646276","title":"A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-02-25","start_date_type":"ACTUAL","primary_completion_date":"2028-04-06","primary_completion_date_type":"ESTIMATED","completion_date":"2031-09-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}